Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
American Psychiatric Association (1989) Diagnostisches and Statistisches Manual Psychischer Storungen DSM-III-R. Beltz, Weinheim
American Psychiatric Association (1996) Diagnostisches and Statistisches Manual Psychischer Storungen DSM-IV Hogrefe, Gottingen
Angst J, Dittrich A, Grof P (1969) The course of endogenous affective psychoses and its modification by prophylactic administration of imipramine and lithium. Int Pharmacopsychiatr 2: 1–11
Angst J, Weiss P, Grof P, Baastrup PC, Schou M (1970) Lithium prophylaxis in recurrent affective disorders. Brit J Psychiat 116: 604–619
Banov MD, Zarate CA, Scialabba BA, Tohen M, Wines J (1993) Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. American Psychiatric Association Annual Meeting, San Francisco, Abstract 163 Bellaire W, Demisch K, Stoll KD (1990) Carbamazepin versus Lithium. M Med Wschr 132: 82–86
Brown R (1989) US experience with valproate in manic depressive illness. A multicenter trial. J Clin Psychiatr 50 (suppl): 3
Delva NJ, Letemendia FJJ (1982) Lithium treatment in schizophrenia and schizoaffective disorders. Br J Psychiat 141: 387–400
Denicoff KD, Meglathery SB, Post RM, Tandeciarz SI (1994) Efficacy of carbamazepine compared with other agents: a clinical practice survey. J Clin Psychiatry 55: 70–76
Egli H (1971) Erfahrungen mit der Lithiumprophylaxe phasischer affektiver Erkrankungen in einer psychiatrischen Poliklinik. Schweiz Med Wschr 101: 157–164
Goodnick PJ, Meltzer HY (1984) Treatment of schizoaffective disorders. Schiz Bull 10: 30–48
Greil W, Ludwig-Mayerhofer W, Erazo N, Engel RR, Czernik A, Giedke H, Müller-Oer-linghausen B, Osterheider M, Rudolf GAE, Sauer H, Tegeler J, Wetterling T (1997) Lithium vs carbamazepine in the maintenance treatment of schizoaffective disorder: a randomised study. Eur Arch Psychiatry Clin Neurosci 247: 42–50
Hofmann G, Kremser M, Katschnig H (1970) Prophylaktische Lithiumtherapie bei manisch-depressivem Krankheitsgeschehen and bei Legierungspsychosen. Int Pharmacopsychiat 4: 187–193
Keck PE, jr, McElroy SL, Strakowski SM, West SA (1994) Pharmacologic treatment of schizoaffective disorder. Psychopharmacology 114: 529–538
Küfferle B, Lenz G (1983) Classification and course of schizoaffective psychoses Follow-up of patients treated with lithium. Psychiat Clin 16: 169–177
Lambert PA (1984) Acute and prophylactic therapies of patients with affective disorders using valpromide (dipropylacetamide). In: Emrich HM, Okuma T, Moller AA (eds) Anticonvulsants in affective disorders. Excerpta Medica, Amsterdam, pp. 3344
Lenz G, Lovrek A, Thau K, Topitz A, Denk E, Simhandl C, Wancata J, Wolf R (1987) Zur Lithiumprophylaxe schizoaffektiver Storungen. Wiener Med Wschr 137: 5–6
Maj M (1988) Lithium prophylaxis of schizoaffective disorders: a prospective study. J Aff Disord 14: 129–135
Mattes JA, Nayak D (1984) Lithium versus fluphenazine for prophylaxis in mainly schizophrenic schizoaffectives. Biol Psychiat 19: 445–449
McElroy SL, Keck PE, Jr, Pope HG Jr (1987) Sodium valproate: its use in primary psychiatric disorders. J Clin Psychopharmacol 7: 16–24
McElroy SL, Dessain EC, Pope HG, jr, Cole JO, Keck PE, jr, Frankenberg FR, Aizley HG, O’Brien S (1991) Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder and schizophrenia. J Clin Psychiatr 52: 411–414
McElroy SL, Keck PE (1993) Treatment guidelines for valproate in bipolar and schizo-affective disorders. Can J Psychiatr 38 (suppl 2): 62–66
Möller HJ (1987) Indikation and Differentialindikation der neuroleptischen Langzeit-medikation. In: Pichot P, Moller HJ (eds) Neuroleptika, Ruckschau 1952-1986 — Künftige Entwicklungen. Springer, Berlin Heidelberg New York, 63–79
Naber D, Hippius H (1980) The European experience with use of clozapine. Hosp Commun Psychiatry 41: 886–890
Perris C (1978) Morbidity suppressive effect of lithium carbonate in cycloid psychosis. Arch Gen Psychiat 35: 328–331
Placidi GF, Lenzi A, Lazzerini F, Cassano GB, Akiskal HS (1986) The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3year trial in 83 patients. J Clin Psychiatr 47: 490–494
Prien RF, Caffey EM Klett CJ (1974) Factors associated with treatment success in lithium carbonate prophylaxis. Arch Gen Psychiatr 31: 189–192
Puzynski S, Klosiewicz L (1984) Valproic acid amide as a prophylactic agent in affective and schizoaffective disorders. Psychopharmacol Bull 20: 151–159
Rosenthal NE, Rosenthal LN, Stallone F, Dunner DL, Fieve RR (1980) Toward the vali-dation of RDC schizoaffective disorder. Ach Gen Psychiat 37: 804–810
Smulevitch AB, Zavidovskaya GI, Igonin AK, Mikhailova M (1974) The effectiveness of lithium in affective and schizoaffective psychoses. Brit J Psychiat 125: 65–72
Spitzer RK, Endicott J, Robins E (1982) Forschungs-Diagnose-Kriterien ( RDC) Beltz, Weinheim Basel
Tress W, Haag H (1979) Vergleichende Erfahrungen mit der rezidivprophylaktischen Lithium- Langzeitmedikation bei schizoaffektiven Psychosen. Nervenarzt 50: 524–526
Weltgesundheitsorganisation (1991) Internationale Klassifikation psychischer St6rungen, ICD-10, Kapitel V Klinisch-diagnostische Leitlinien, Huber, Bern
Zarate CA, Tohen M, Banov MD, Weiss MK, Cole JO (1995) Is clozapine a mood stabilizer? J Clin Psychiatry 56: 108–112
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lenz, G., Bankier, B. (1997). Prophylaxe der schizoaffektiven Psychosen. In: Müller-Oerlinghausen, B., Berghöfer, A., Greil, W. (eds) Die Lithiumtherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60819-3_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-60819-3_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64570-9
Online ISBN: 978-3-642-60819-3
eBook Packages: Springer Book Archive